This inventor holds 1 USPTO granted patent. Top assignee: Takashi Muramatsu. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Kazuhiro Toriyama: Innovator in Inflammatory Disease Treatment
Introduction
Kazuhiro Toriyama is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of inflammatory diseases. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Kazuhiro Toriyama holds a patent for "Agents comprising midkine or an inhibitor thereof as active ingredient." Midkine (MK) is a retinoic acid-inducible heparin-binding growth factor that enhances neutrophilic migration. It exists in an inflammatory state at a high concentration. The midkine or its inhibitors can be utilized for treating neutrophilic functional disorders or inflammatory diseases. This patent highlights his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Kazuhiro Toriyama has worked diligently in the field of medical research. He is associated with Takashi Muramatsu, where he has collaborated with other professionals to further his research and innovations. His work has been instrumental in developing therapies that can improve patient outcomes.
Collaborations
Kazuhiro has collaborated with notable colleagues such as Tohru Takada and Hisako Muramatsu. These partnerships have allowed him to expand his research and contribute to significant advancements in the medical field.
Conclusion
Kazuhiro Toriyama is a distinguished inventor whose work in the treatment of inflammatory diseases has made a lasting impact. His patent on midkine and its inhibitors showcases his innovative spirit and dedication to improving healthcare. His contributions continue to inspire future research and development in the medical community.